Lipoprotein(a) Management Simplified: The National Lipid Association Lipid Simplified Series

This document aims to provide practical guidance on testing and management of Lp(a) for primary and secondary ASCVD risk management.

S7E10: Fresh from Munich: Plozasiran and the SHASTA-3 & SHASTA-4 Trial Results

Hot off the European Society of Cardiology Congress in Munich, this Lipid Insights episode takes a closer look at a significant announcement in triglyceride science…

S6E5: Recognition and Management of Persistent Chylomicronemia

Dive into the complexities of Persistent Chylomicronemia with this special episode recorded live at the recent National Lipid Association Scientific Sessions. Guest host Christie Ballantyne,…

LDL Cholesterol Management Simplified in Adults—Lower for Longer is Better: Guidance from the National Lipid Association

The primary goals for LDL-C management are to achieve an acceptable level for the patient’s risk category and to maintain that over time.

Recognition and Management of Persistent Chylomicronemia: A Joint Expert Clinical Consensus by the National Lipid Association and the American Society for Preventive Cardiology

Patients with persistent chylomicronemia and alarm features have a very high risk of acute pancreatitis, similar to FCS.

Role of apolipoprotein B in the Clinical Management of Cardiovascular Risk in Adults: An Expert Clinical Consensus from the National Lipid Association

ApoB represents the total concentration of atherogenic lipoprotein particles in the circulation and more accurately reflects the atherogenic burden of lipoproteins when compared to low-density…

S5E1: A Focused Update to the 2019 NLA Scientific Statement On The Use of Lp(a) in Clinical Practice

Alan Brown, MD, FACC, MNLA talks with Christie Ballantyne, MD, FNLA about the publication of “A Focused Update to the 2019 NLA Scientific Statement On…

So Which Guideline & Risk Scoring System Should I Use?